Journal profile
ImmunoAnalysis
ISSN 2783-2589 · Tabriz University of Medical Sciences · Iran, Islamic Republic of
ImmunoAnalysis: diamond open access (no APC); no APC; review about 8 weeks (community reports); 1 articles in 2025.
Scope
Aims, scope and focus
ImmunoAnalysis is published by Tabriz University of Medical Sciences. By OpenAlex counts of its recent articles, its largest topics are Electrochemical sensors and biosensors, Cancer Immunotherapy and Biomarkers and Immunotherapy and Immune Responses, together about 19.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
ImmunoAnalysis is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with immunoanalysis. The main aims of this journal are to publish up-to-date articles in the field of immunoanalysis, expansion and development of knowledge in the fields of pharmaceutical analysis and immunology and other related fields, actively working towards addressing the world's scientific and research demands in the immunoanalysis sector, and facilitating the sharing of new research insights in immunoanalysis, thereby expanding the horizons of human knowledge. ImmunoAnalysis encourages submission of manuscripts related to developing bioanalysis methods such as quantification of small molecules, peptides, proteins, antibodies biomarkers and immunoassay methods, and studies in immunology field such as innate immunity and inflammation; development; immune receptors, cellular and systemic immunity; vaccines; immune tolerance; autoimmunity and tumor immunology, microbial immunopathology, novel or improved cutting-edge analytical platforms, methods and sensors for rapid and accurate measurement of pharmaceutical, biomedical, or natural products. Research Areas Include: • Immunoassay methods • Analytical approaches for omics development • Biosensor and pharmaceutical analysis • Bioanalysis and bioactivity assays • Biomarker’s analysis • Extraction and purification of immune drugs • Immunology • Tumor markers • Immuno and cheminformatics • Tumor immunology • Immunopharmacology
From the journal's Aims & Scope
Main research topics OpenAlex counts of recent articles; shares are approximate
- Electrochemical sensors and biosensorsEngineering7.2%
- Cancer Immunotherapy and BiomarkersMedicine6%
- Immunotherapy and Immune ResponsesImmunology and Microbiology6%
- Chronic Lymphocytic Leukemia ResearchMedicine6%
- vaccines and immunoinformatics approachesBiochemistry, Genetics and Molecular Biology6%
- COVID-19 Clinical Research StudiesMedicine4.8%
- SARS-CoV-2 and COVID-19 ResearchMedicine4.8%
- Analytical chemistry methods developmentChemistry4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 6OpenAlex ·
- i10-index
- 2OpenAlex ·
- 2-year mean citedness
- 0.62OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 52 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 16 |
| 2025 | 1 | 1 | 37 |
| 2024 | 12 | 12 | 30 |
| 2023 | 13 | 13 | 15 |
| 2022 | 14 | 14 | 7 |
| 2021 | 12 | 12 | 3 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
Too few articlesOnly 3 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 3
- Cover letter
- Required
Article types accepted5
- editorialEditorial: The Journal’s editors write the editorial.Length not stated
- letterLetter: Comments or concerns on specific subjects; overall or pertaining to items published in the journal. Also, new or additional findings of original nature.Length not stated
- research articleResearch article: Original work resulting from research, constituting complete studies that contain all relevant information. Including systematic review and me…Length not stated
- reviewReview: Narrative reviews on clinically relevant topics.Length not stated
- short communicationShort communication: Original work, but less substantial than the regular research article, presenting preliminary results, or results of immediate relevance.Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, License & copyright, Peer review, Plagiarism
- Authorship Author Contribution
Authors should provide the information related to the Authors' Contribution section (CRediT) when submitting the article. If the Authors’ Contribution section is not sent at the time of submitting the article, it must be submitted when sending the corrections requested by the reviewers. The corresponding author is responsible for the accuracy and validity of the information. The Authors' Contribut…
Source ↗Publisher website ·- Data availability Data Sharing
Data sharing encouraged. Model summary
ImmunoAnalysis encourages authors to share the data and any other material associated with methodology and the results of the submitted articles, in an appropriate public repository, or as open access supplementary to the article. In line with ICMJE recommendations, a data sharing statement is required for manuscripts reporting the results of clinical trials, on whether and how the data will be av…
Source ↗Publisher website ·- License & copyright
CC-BY 4.0 license; authors retain copyright. Model summary
The authors retain the copyright to their work without restrictions, licensing under the Creative Commons license 4.0 (CC-BY).
Source ↗Publisher website ·- Peer review
Double-blind peer review process. Model summary
Since all papers will undergo a double-blind peer review process
Source ↗Publisher website ·- Plagiarism
iThenticate software used for plagiarism checking. Model summary
We use iThenticate software in the processing of the submissions.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Tabriz University of Medical Sciences
- Country or region
- Iran, Islamic Republic of
- Language
- English
- ISSN
- 2783-2589
- Society / sponsor
- Pharmaceutical Analysis Research Center
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about ImmunoAnalysis
How long does peer review take at ImmunoAnalysis?
Authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of ImmunoAnalysis?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 3; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index ImmunoAnalysis?
According to LetPub and DOAJ records, ImmunoAnalysis is indexed in DOAJ.
Is ImmunoAnalysis open access, and what is the APC?
ImmunoAnalysis is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .